These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38757270)

  • 1. Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy.
    Lin CY; Huang PW; Hsieh CH; Hsu CL; Liau CT; Huang SF; Liao CT; Chang TC; Wang HM
    Nutr Cancer; 2024; 76(7):628-637. PubMed ID: 38757270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.
    Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM
    Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma.
    Ahn D; Sohn JH; Kim JH; Lee JE; Park SH; Kim JC
    Ear Nose Throat J; 2016 Feb; 95(2):E34-42. PubMed ID: 26930342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial.
    Hsieh CH; Lin CY; Hsu CL; Fan KH; Huang SF; Liao CT; Lee LY; Ng SK; Yen TC; Chang JT; Lin JR; Wang HM
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):33-41. PubMed ID: 31728618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
    Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
    Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
    Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
    Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
    Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer.
    Chitapanarux I; Tharavichitkul E; Kamnerdsupaphon P; Pukanhapan N; Vongtama R
    J Radiat Res; 2013 Nov; 54(6):1110-7. PubMed ID: 23740894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation for advanced oral and (pharyngo) laryngeal carcinoma: single institution outcome analysis.
    Dequanter D; Shahla M; Aubert C; Deniz Y; Lothaire P
    Minerva Stomatol; 2015 Jun; 64(3):111-5. PubMed ID: 25799444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Kwok Y; Goloubeva O; Parekh A; Taylor R; Wolf J; Zimrin A; Strome S; Ord R; Cullen KJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1845-50. PubMed ID: 21601372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.
    Jackson W; Alexander N; Schipper M; Fig L; Feng F; Jolly S
    Head Neck; 2014 Sep; 36(9):1356-62. PubMed ID: 23970480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
    Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
    Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.